Chongqing Lummy Pharmaceutical Co Ltd represents values of innovation, excellence, and sustainability in the pharmaceutical industry. As a leading company, Chongqing Lummy Pharmaceutical is committed to delivering high-quality healthcare solutions and improving the well-being of its consumers. With a customer-centric approach, the company focuses on research and development, constantly striving to introduce new and effective medicines. Guided by a corporate philosophy that emphasizes integrity, collaboration, and social responsibility, Chongqing Lummy Pharmaceutical contributes to the advancement of healthcare globally. Through its dedication to excellence and a strong commitment to ethical practices, the company has earned a reputable name in the pharmaceutical sector.

Chongqing Lummy Pharmaceutical Co Ltd primarily operates in the domestic Chinese market. With its headquarters in Chongqing, China, the company focuses on the research, development, production, and sale of pharmaceutical products. As an established player in the pharmaceutical industry, Chongqing Lummy Pharmaceutical Co Ltd serves customers across various regions and provinces in China. Through its extensive distribution network and collaborations, the company ensures that its products are readily available to meet the healthcare needs of Chinese consumers. With a strong presence in its home country, Chongqing Lummy Pharmaceutical Co Ltd continues to contribute to the advancement of healthcare in China.

Chongqing Lummy Pharmaceutical Co Ltd has achieved several significant milestones in its history. Notably, the company successfully gained approval for its innovative drug in the treatment of cancer, which has revolutionized the medical industry. Additionally, Chongqing Lummy Pharmaceutical Co Ltd expanded its market presence globally and established strategic partnerships with renowned pharmaceutical companies. Furthermore, the company received numerous accolades for its continuous dedication to research and development, ensuring the delivery of high-quality pharmaceutical products. Overall, Chongqing Lummy Pharmaceutical Co Ltd has consistently demonstrated its commitment to innovation, market expansion, and improving patient outcomes in the healthcare sector.

Chongqing Lummy Pharmaceutical Co Ltd, a renowned company in the pharmaceutical industry, has a rich history and promising background. Established in (year), Chongqing Lummy has evolved as a leading player in the pharmaceutical market. Renowned for their commitment to quality and innovation, the company specializes in (specific products or treatments). With a strong focus on research and development, Chongqing Lummy has successfully introduced cutting-edge solutions that cater to the diverse needs of patients. Their dedication to providing reliable healthcare solutions has earned them a reputable position in the industry. Chongqing Lummy Pharmaceutical Co Ltd continues to thrive, driven by their mission to enhance people's wellbeing with their top-notch pharmaceutical offerings.

The main competitors of Chongqing Lummy Pharmaceutical Co Ltd in the market are [insert names of competitors]. These competitors operate in the [specify relevant industry or market], offering similar products and services. Chongqing Lummy Pharmaceutical Co Ltd faces competition in terms of [mention key areas of competition such as product range, market share, pricing, quality, etc.]. With its focus on [mention unique selling points or strengths of Chongqing Lummy Pharmaceutical Co Ltd], the company strives to differentiate itself and maintain a competitive edge in the market.

Chongqing Lummy Pharmaceutical Co Ltd is primarily active in the pharmaceutical industry.

The business model of Chongqing Lummy Pharmaceutical Co Ltd is focused on the development, manufacturing, and distribution of pharmaceutical products. With a strong emphasis on research and technology, the company strives to deliver high-quality and innovative healthcare solutions to meet the needs of patients. Chongqing Lummy Pharmaceutical Co Ltd aims to establish itself as a leading player in the pharmaceutical industry by expanding its product portfolio, maintaining regulatory compliance, and establishing strategic partnerships. By leveraging its expertise and resources, the company aims to provide effective and affordable medicines that enhance the well-being of individuals and contribute to the advancement of healthcare.

Současně nelze vypočítat KGV pro Chongqing Lummy Pharmaceutical Co.

KUV pro Chongqing Lummy Pharmaceutical Co nelze v současné době vypočítat.

AlleAktien kvalitní skóre pro Chongqing Lummy Pharmaceutical Co je 2/10.

Tržby pro Chongqing Lummy Pharmaceutical Co nelze v současné době vypočítat.

Zisk pro Chongqing Lummy Pharmaceutical Co nelze v současnosti vypočítat.

Chongqing Lummy Pharmaceutical Co Ltd is a pharmaceutical company specializing in the development, manufacturing, and marketing of pharmaceuticals and healthcare products. The company is based in Chongqing, China and has been operating in the industry since 2003. The business model of Chongqing Lummy Pharmaceutical Co Ltd includes five areas of operation: research and development, production, distribution, marketing, and healthcare services. These areas are described in more detail below: Research and Development (R&D): Chongqing Lummy Pharmaceutical Co Ltd continuously invests in R&D for new pharmaceuticals and healthcare products. The company has an R&D team composed of experienced scientists and experts who collaborate closely with leading universities and research institutes to develop innovative solutions. R&D activities focus on areas such as cancer, diabetes, cardiovascular diseases, metabolic disorders, and gastroenterology. Production: Chongqing Lummy Pharmaceutical Co Ltd has modern facilities and production sites to ensure high quality and efficiency in manufacturing. The company specializes in the production of pharmaceuticals including analgesics, anti-rheumatics, anti-cancer drugs, and anti-infectives, as well as healthcare products such as vitamin tablets and dietary supplements. Distribution: Chongqing Lummy Pharmaceutical Co Ltd distributes its products through distribution channels across China. The company works with pharmacies, hospitals, medical centers, and specialty stores to ensure its products are available where needed. Marketing: Chongqing Lummy Pharmaceutical Co Ltd has an experienced marketing team to successfully promote its products. The company employs various marketing strategies including advertising in print and digital media, social media marketing campaigns, and participation in industry exhibitions and conferences. Healthcare Services: Chongqing Lummy Pharmaceutical Co Ltd also offers healthcare services. The company collaborates with healthcare professionals such as doctors, nurses, and pharmacists to provide comprehensive healthcare. Services include consultation on healthcare products, health checks, and information on preventive measures. In addition to the above-mentioned areas of operation, Chongqing Lummy Pharmaceutical Co Ltd also offers a variety of products tailored to the different needs and requirements of its customers. These include a wide range of pharmaceuticals and healthcare products that contribute to improving people's health and well-being. Overall, Chongqing Lummy Pharmaceutical Co Ltd has a solid business model based on R&D, production, distribution, marketing, and healthcare services. Through providing innovative products and services and collaborating with healthcare professionals, the company has become a leading player in the pharmaceutical industry in China.

Chongqing Lummy Pharmaceutical Co vyplácí dividendu ve výši 0 CNY rozdělenou do výplat během roku.

Dividenda pro Chongqing Lummy Pharmaceutical Co momentálně nemůže být vypočítána nebo společnost žádnou dividendu nevyplácí.

ISIN společnosti Chongqing Lummy Pharmaceutical Co je CNE100000H10.

Ticker společnosti Chongqing Lummy Pharmaceutical Co je 300006.SZ.

Během posledních 12 měsíců vyplatila společnost Chongqing Lummy Pharmaceutical Co dividendu ve výši 0,05 CNY . To odpovídá dividendovému výnosu přibližně 1,03 %. Pro nadcházejících 12 měsíců se očekává, že Chongqing Lummy Pharmaceutical Co vyplatí dividendu ve výši 0 CNY.

Výnos z dividend společnosti Chongqing Lummy Pharmaceutical Co aktuálně činí 1,03 %.

Chongqing Lummy Pharmaceutical Co vyplácí čtvrtletní dividendu. Ta je distribuována v měsících srpen, září, srpen, srpen.

Chongqing Lummy Pharmaceutical Co vyplácela v posledních 0 letech každý rok dividendu.

Očekává se, že v následujících 12 měsících budou dividendy ve výši 0 CNY. To odpovídá dividendovému výnosu 0 %.

Chongqing Lummy Pharmaceutical Co je přiřazen k sektoru 'Zdraví'.

Aby ses mohl podílet na poslední dividendě Chongqing Lummy Pharmaceutical Co ve výši 0,05 CNY, zaznamenané 3. 7. 2020, měl jsi mít akcii ve svém portfoliu před ex-dnem 3. 7. 2020.

Poslední dividendy byly vyplaceny dne 3. 7. 2020.

V roce 2023 společností Chongqing Lummy Pharmaceutical Co bylo vyplaceno 0 CNY ve formě dividend.

Dividendy společnosti Chongqing Lummy Pharmaceutical Co jsou vypláceny v CNY.